146 related articles for article (PubMed ID: 22170735)
21. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
22. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
Swartz MS; Wagner HR; Swanson JW; Stroup TS; McEvoy JP; Canive JM; Miller DD; Reimherr F; McGee M; Khan A; Van Dorn R; Rosenheck RA; Lieberman JA
J Nerv Ment Dis; 2006 Mar; 194(3):164-72. PubMed ID: 16534433
[TBL] [Abstract][Full Text] [Related]
23. Substance abuse and schizophrenia: pharmacotherapeutic intervention.
Green AI; Noordsy DL; Brunette MF; O'Keefe C
J Subst Abuse Treat; 2008 Jan; 34(1):61-71. PubMed ID: 17574793
[TBL] [Abstract][Full Text] [Related]
24. Polypharmacy in schizophrenia.
Zink M; Englisch S; Meyer-Lindenberg A
Curr Opin Psychiatry; 2010 Mar; 23(2):103-11. PubMed ID: 20051861
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
Wobrock T; D'Amelio R; Falkai P
Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
[TBL] [Abstract][Full Text] [Related]
26. Predictors of clozapine discontinuation in patients with schizophrenia.
Krivoy A; Malka L; Fischel T; Weizman A; Valevski A
Int Clin Psychopharmacol; 2011 Nov; 26(6):311-5. PubMed ID: 21849905
[TBL] [Abstract][Full Text] [Related]
27. Psychoses in the elderly: a spectrum of disorders.
Targum SD; Abbott JL
J Clin Psychiatry; 1999; 60 Suppl 8():4-10. PubMed ID: 10335666
[TBL] [Abstract][Full Text] [Related]
28. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia.
Buckley PF
J Subst Abuse Treat; 1998; 15(2):113-6. PubMed ID: 9561949
[TBL] [Abstract][Full Text] [Related]
29. Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis.
Krause M; Huhn M; Schneider-Thoma J; Bighelli I; Gutsmiedl K; Leucht S
Eur Neuropsychopharmacol; 2019 Jan; 29(1):32-45. PubMed ID: 30472164
[TBL] [Abstract][Full Text] [Related]
30. Treatment of dual diagnosis disorders.
Murthy P; Chand P
Curr Opin Psychiatry; 2012 May; 25(3):194-200. PubMed ID: 22395768
[TBL] [Abstract][Full Text] [Related]
31. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
Arranz B; Garriga M; García-Rizo C; San L
Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
[TBL] [Abstract][Full Text] [Related]
32. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological treatment of schizophrenia with comorbid substance use disorder.
Azorin JM; Simon N; Adida M; Belzeaux R
Expert Opin Pharmacother; 2016; 17(2):231-53. PubMed ID: 26635059
[TBL] [Abstract][Full Text] [Related]
34. The pharmacological management of violence in schizophrenia: a structured review.
Topiwala A; Fazel S
Expert Rev Neurother; 2011 Jan; 11(1):53-63. PubMed ID: 21158555
[TBL] [Abstract][Full Text] [Related]
35. Can antipsychotic treatment contribute to drug addiction in schizophrenia?
Samaha AN
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():9-16. PubMed ID: 23793001
[TBL] [Abstract][Full Text] [Related]
36. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
37. A neurobiological basis for substance abuse comorbidity in schizophrenia.
Chambers RA; Krystal JH; Self DW
Biol Psychiatry; 2001 Jul; 50(2):71-83. PubMed ID: 11526998
[TBL] [Abstract][Full Text] [Related]
38. The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic study.
Alisauskiene R; Løberg EM; Gjestad R; Kroken RA; Jørgensen HA; Johnsen E
Nord J Psychiatry; 2019; 73(4-5):281-287. PubMed ID: 31140342
[No Abstract] [Full Text] [Related]
39. Clozapine for substance-abusing schizophrenic patients.
Tsuang JW; Eckman TE; Shaner A; Marder SR
Am J Psychiatry; 1999 Jul; 156(7):1119-20. PubMed ID: 10401473
[No Abstract] [Full Text] [Related]
40. [Comorbid addictive disorders and schizophrenia in the aspect of pathogenesis and treatment].
Eryshev OF; Arkad'ev VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 2):67-73. PubMed ID: 21322149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
